• Tue, May 14, 2024
Serge Belanger Maintained (VRCA) at Strong Buy with Increased Target to $16 on, May 14th, 2024
Serge Belanger of Needham, Maintained "Verrica Pharmaceuticals Inc." (VRCA) at Strong Buy with Increased Target from $8 to $16 on, May 14th, 2024.
Serge, nor any peers, have made any analyst calls on VRCA in the last 4 months.
Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30Like: 👍
